Market Access Expansion Stratevi is strengthening its market access and value communications capabilities with new senior leadership and a dedicated access communications capability, signaling opportunities to sell expanded services to pharmaceutical and life sciences clients seeking clearer payer narratives and improved therapy access.

Medical Affairs Growth Recent hires and the launch of a medical affairs practice indicate a strategic push into field medical and medical affairs collaborations, creating upsell opportunities for integrated HEOR, medical communications, and field-facing support.

Integrated Solutions Stratevi’s suite spans economic models, real world evidence, study design, and publications, offering cross-sell potential to clients needing end-to-end evidence generation and value dossiers for payer submissions, brand access, and publication strategy.

Strategic Partnerships With a focus on value proposition development, competitive simulations, and ICER reviews, there is a clear path to partner with biotech, pharma, and medical device companies aiming to optimize market access strategies and competitive positioning.

Scale Readiness Revenue indicates a mid-market scale (50M–100M) and a lean headcount; growth opportunities exist in expanding client base within biotech and pharma segments, leveraging software like StrateFlow and digital training to boost project efficiency and client outcomes.